Literature DB >> 8637540

Postherpetic neuralgia--pathogenesis, treatment, and prevention.

R G Kost1, S E Straus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8637540     DOI： 10.1056/NEJM199607043350107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  111 in total

1.  Postherpetic neuralgia. Findings differ from earlier results.

Authors:  D Bowsher
Journal:  BMJ       Date:  2001-04-07

Review 2.  Antiviral therapies for herpes zoster infections. Are they economically justifiable?

Authors:  K J Smith; M S Roberts
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

3.  Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication.

Authors:  Robert J Visalli; Jeanette Fairhurst; Shamala Srinivas; William Hu; Boris Feld; Martin DiGrandi; Kevin Curran; Adma Ross; Jonathan D Bloom; Marja van Zeijl; Thomas R Jones; John O'Connell; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Post-shingles neuralgia by any definition is painful, but is it PHN?

Authors:  Barbara P Yawn
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 5.  Treatment of herpes zoster.

Authors:  Wim Opstelten; Just Eekhof; Arie Knuistingh Neven; Theo Verheij
Journal:  Can Fam Physician       Date:  2008-03       Impact factor: 3.275

6.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

7.  Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.

Authors:  Sheng-mei Zhu; Yong-min Liu; Er-dan An; Qing-lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2009-08       Impact factor: 3.066

8.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Natural history of pain following herpes zoster.

Authors:  Hans Gustav Thyregod; Michael C Rowbotham; Michelle Peters; Jessica Possehn; Marlene Berro; Karin Lottrup Petersen
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

10.  Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.

Authors:  Hiltrud Liedgens; Nadine Hertel; Anja Gabriel; Mark Nuijten; Helen Dakin; Stephen Mitchell; Barbara Poulsen Nautrup
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.